Sexual dysfunction and BPH appear to be strongly associated in older men, according to two new studies.
Information and Guidance on the Adoption of Surgical Innovation and Technology in Urogynecology
The aim of this document is to present a framework by which AUGS and its members can address the development of new technology and techniques, particularly in the surgical arena.
Dr. Schwen on focal therapies for prostate cancer
Zeyad Schwen, MD, a urologic oncologist at Cleveland Clinic, discusses how patient factors and cancer characteristics are key to deciding between focal therapies and whole gland treatment for prostate cancer.
PSMA-PET leads imaging breakthroughs in prostate cancer paradigm
Daniel Spratt, MD, highlights the evolving paradigm of PET-based imaging agents in prostate cancer, with a focus on the impact of PSMA-PET imaging.
Speaking of Urology: Liquid biopsy in prostate cancer
In this episode, David M. Albala, MD, and Sanoj Punnen, MD, discuss precision medicine and the use of biomarker tests in prostate cancer screening and detection.
Study launches of BNT316/ONC-392 plus radioligand therapy in mCRPC
In total, the phase 1/2 PRESERVE-006 trial is expected to enroll 144 patients across 20 clinical trial sites in the US.
Trial to investigate efficacy of aloe vera in patients with interstitial cystitis
"We have over 30 years of safety data, and no adverse events in over 30 years," says Heather Florio.
2 Commerce Drive Cranbury, NJ 08512